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INTRODUCTION
Ethics review by an independent committee is es-
sential for research involving human subjects. In
Japan, clinical trials leading to the approval of drugs
(registration trials) are regulated by pharmaceutical
affairs laws. In 1998, Good Clinical Practice (GCP),
originally approved by the International Confer-
ence on Harmonisation of Technical Requirements
for Registration of Pharmaceuticals for Human Use
(ICH) was effectively deployed in all registration
trials, and registration trials are reviewed by commit-
tees that meet GCP. In contrast, engaging an ethics
committee to review investigator-initiated research
took place for the first time in Japan at the Univer-
sity of Tokushima in 1982, not as a response to na-
tional directives. Gradually, ethics committees in
Japan have increased in number, and by the 1990s,
Saito (1) surveyed 80 medical schools by question-
naire in 1991 and reported that ethics committees
had been established in 79 of them. Akabayashi et
al. reported the status of Japanese medical schools
and the number of general hospital ethics commit-
tees in 1997 (2), as well as the number of ethics
committees in medical organizations in 1998 (3).
Although originally Japanese ethics committees
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were established voluntarily, after the enforcement
of ethical guidelines by the ministries of Japan in
2001, ethics committees were required to act in ac-
cordance with these ethical guidelines. At the same
time, investigators of medical institutions, such as
clinics, found it difficult to establish their own eth-
ics committees. Thus, requesting ethical review
from the ethics committee of other medical insti-
tutions was encouraged. The ethics committee of
Tokushima University Hospital started to review ap-
plications from other institutions in 2003, and com-
munication between medical institutions in the re-
gional area has become more important. Although
Sasaguri et al. (4) reported the survey results on the
status of ethics committees in Fukuoka Prefecture
in 2007, there is still little information known about
this particular region.
We surveyed the performance of clinical trials and
the status of ethics committees in the Shikoku re-
gion of Tokushima Prefecture, a rural area of Japan,
and reported the survey results. Considering the
situation in Japan as described above, in the present
article, “ethics committee” is defined as a commit-
tee that reviews investigator-initiated research and
is primarily established in a medical institution.
METHODS
The ethics committee of Tokushima University
Hospital began reviewing applications from other
institutions in 2003. At first, we analyzed the records
of the ethics committee of Tokushima University
Hospital to determine the number of applications
from other medical institutions.
We assessed the performance of clinical trials and
the status of ethics committees in Tokushima Pre-
fecture by using a cross-sectional study in collabo-
ration with the Tokushima Medical Association.
A questionnaire was specifically designed for use
in this study. The questionnaire was anonymous and
contained two parts with 24 questions. The first part
consisted of two questions to determine the per-
formance of clinical trials in each medical institution.
The second part consisted of 22 questions, such as
the presence of ethics committees, their activities,
their structure, and education for the members. The
questionnaire was provided to all medical institu-
tions (n=737) registered to the Tokushima Medical
Association in 2012. The consent of each institution
was implied by filling out the questionnaire.
Due to the limited number of medical institutions
included in this study, no statistical analysis of the
data was performed.
This study was approved by the Ethics Commit-
tee of Tokushima University Hospital.
RESULTS
Applications from other medical institutions for eth-
ics review by the ethics committee of Tokushima
University Hospital
The ethics committee accepts applications for re-
view of studies conducted in institutes other than the
University of Tokushima when the studies are simul-
taneously conducted in the University of Tokushima.
From April, 2003 to March, 2014, all 1780 protocols
from investigators of the University of Tokushima
were reviewed, and among these, 274 applications
from other institutions were reviewed.
Respondents and their clinical research performance
status
Among the 737 medical institutions registered to
the Tokushima Medical Association, 223 (30.3%)
questionnaires were returned and 221 (30.0%) were
completed and included in this analysis (respon-
dents). Table 1 reports the attributes of the respon-
dents. The recovery of questionnaires in hospitals
was significantly higher than clinics (P=0.0027).
As shown in table 2, among respondents, 51 (23.1%)
had performed clinical research. The experience
Table 1. Attributes of subjects for this survey
N=737
Medical institutions Respondents
N(%)
No response
N(%)
P value*
Hospital (n=115) 49 (42.6) 66 (57.4)
0.0027
Clinic (n=622) 174 (28.0) 448 (72.0)
Total 223 (30.3) 514 (69.7)
* Chi-square test
Table 2. Number of institutions with or without experience
performing clinical research
N=221
Medical institutions Performing of clinical trials P value*
Eexperience
N(%)
No experience
N(%)
Hospital (n=49) 21 (42.9) 28 (57.1)
0.0004
Clinic (n=172) 30 (17.4) 142 (83.0)
Total 51 (23.1) 170 (77.3)
* Chi-square test
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rate of clinical trials in hospitals was significantly
higher than clinics (P=0.0004). Answers from 170
medical institutions stated that the primary reasons
for the lack of experience of conducting clinical re-
search were no arrangement of an ethics commit-
tee, no interest, lack of available assistants, and no
chance to participate (Figure 1). Regarding the will-
ingness to participate, 50 medical institutions (29.4%)
responded that they were willing to conduct clinical
research if the reasons stated above (no arrange-
ment of an ethics committee, lack of available assis-
tants, and no chance to participate) were overcome.
Status of ethics committees in respondent institutions
Among 51 medical institutions that had experience
performing clinical research, 17 (33.3%) answered
to have established ethics committees, 31 (60.8%)
answered not to have established ethics committees,
and 3 (5.9%) provided no answer (Figure 2).
Quality assurance of ethics committees
We analyzed issues concerning quality assurance
of ethics reviews in 17 medical institutions that es-
tablished an ethics committee. Among 17, one was
omitted from the following analysis due to an un-
satisfactory answer. Among 16 ethics committees,
14 (87.5%) were confident that all studies applied
for ethical review. Review of protocol amendments
and of serious adverse events were reviewed in 10
(62.5%), and 9 (56.3%) ethics committees, respec-
tively. Annual follow-up of approved protocols was
conducted in 6 committees (37.5%) and disclosure of
the review results was done in 6 committees (37.5%)
(Figure 3). As for the necessity to communicate
among ethics committees to promote quality, 11
(68.8%) agreed, 4 (25.0%) were neutral and 1 (6.3%)
disagreed.
Research ethics education for committee members
and investigators
Although 8 (50.0%) realized the need for educa-
tion of committee members, 4 (25.0%) have opportu-
nities for education. As for research ethics education
for investigators, 10 (62.5%) realized the need, and
Figure 1 Primary reasons for the lack of experience of clinical research
Each respondent may give multiple reasons. Respondents intend to perform clinical research if their stated issues were resolved. The
most common reason was that there was no arrangement for an ethics committee.
Figure 2 The status of ethics committees in 51 medical institutions
In 51 medical institutions with clinical research experience, 17 medical institutions (33.3%) established an ethics committee (gray bar) ;
31 medical institutions (60.8%) have not established an ethics committee (black bar) ; and 3 medical institutions (5.9%) did not pro-
vide an answer (white bar).
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4 (25.0%) answered they currently have opportuni-
ties for education. Regarding the desirable frequency
for education opportunities, 3 medical institutions
answered once every 6 months or once a year, and
one answered 3 times every 6 months or once every
3 years.
DISCUSSION
To survey the status of ethics committees, the first
issue is the selection of target institutions. In the
survey in Fukuoka Prefecture (4), Sasaguri et al. se-
lected hospitals and research institutions as targets,
and omitted clinics from the survey. In the present
study, we sent questionnaires to all medical institu-
tions that were registered with the Tokushima Medi-
cal Institution, including clinics. We did this because
this survey was planned around the Tokushima
Medical Institution, and we wanted to know the
complete status, including the performance of clini-
cal research, in each medical institution. Sasaguri
et al. (4) reported on 137 committees, and among
these, 71 committees reviewed registration trials
only. That means the remaining 66 were “ethics
committees” as defined above in the present article.
The recovery was rather low (30.3%), and we found
17 ethics committees in Tokushima Prefecture.
Considering the population of the two prefectures
(Fukuoka with 5 million and Tokushima with 0.8
million), we obtained many answers from medical
institutions, and considered them worth analyzing.
Originally, ethics committees in Japan were vol-
untarily established. After the enforcement of gov-
ernmental guidelines, such as the Ethical Guideline
for Human Genome and Gene Analysis Research
in 2001, the Ethical Guideline for Epidemiological
Research in 2002, and the Ethical Guideline for
Clinical Studies in 2003, ethics committees became
mandatory for medical institutions that conduct this
type of research. The Governmental Ethical Guide-
line for Clinical Studies was revised and enforced in
2009. Under the revised guideline, administrators of
the committee must open the activity to the public
and report to the ministry annually. The provision
for compensation for clinical studies on the evalu-
ation of drugs and medical devices has been added.
Nevertheless, less than half of the institutions (n=
6, 37.5%) answered that they do annual follow-up of
approved protocols. As for research ethics educa-
tion for committee members and investigators, one
quarter of institutions answered that they have op-
portunities for education, though more than half of
the institutions realized the need.
An important issue for Japanese ethics commit-
tees is quality assurance. Although the structure and
functions are basically defined in governmental eth-
ics guidelines, a system to assure the quality of eth-
ics committees is still unsatisfactory. The ethical
guidelines for Epidemiological Research and Clinical
Studies are to be integrated soon. In the new draft
guidelines, a paragraph about quality assurance is
being considered. Moreover, a governmental certi-
fication system for ethics committees is also being
Figure 3 Quality assurance of ethics committees in the 16 medical institutions that have established ethics committees
The figure shows the ratio of enforcement regarding the review of all protocols, review of protocol amendments, review of serious ad-
verse events, annual follow-up of approved protocols, and disclosure of the review results in 16 medical institutions. The black bar
shows that they have enforced the review. The white bar shows that they have not enforced the review.
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discussed. In this survey, it was suggested that a
system with an acceptable level of oversight was
currently in place to review all protocols before the
research begins, but the system was not developed
enough to review the amendment of protocols, se-
rious adverse events, and annual follow-up of ap-
proved protocols. While in the ethics committee of
each medical institution, it is difficult to observe the
governmental ethical guidelines completely to as-
sure the quality of the committees. Until now, each
institution and hospital attempted to establish its
own ethics committee. Now, the use of one ethics
committee by several institutions is being discussed
in Japan for quality assurance.
Tokushima University Hospital established the
“Tokushima Network for Clinical Trials” (TNCT)
in collaboration with the Tokushima Medical Asso-
ciation in 2004 (5). This step was originally planned
for Tokushima University Hospital to contribute in
the region by promoting registration trials. The com-
mittee of Tokushima University Hospital that re-
views registration trials also reviews registration
trials in medical institutions that are registered to
the TNCT free of charge in the event the same reg-
istration trial was done at Tokushima University
Hospital. Like local research ethics committees in
the UK (6), it is an effective strategy to have the
ethics committee of Tokushima University Hospital
play a role as a local research ethics committee.
Practical issues, such as financing, should be re-
solved to encourage this strategy.
In the present study, we investigated the status of
ethics review for clinical research in one region of
Japan. Based on the results, we will continue to sup-
port establishing an appropriate system for the ethi-
cal conduct of health-related research in Tokushima
Prefecture.
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